5N Plus Ownership
FPLSF Stock | USD 8.97 0.16 1.75% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
FPLSF |
FPLSF Pink Sheet Ownership Analysis
About 46.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. 5N Plus recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. 5N Plus Inc. produces and sells semiconductors in North America, Europe, and Asia. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial applications.5N Plus Inc. is headquartered in Montreal, Canada. 5N Plus is traded on OTC Exchange in the United States.The quote for 5N Plus is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about 5N Plus call Gervais Jacques at 514 856 0644 or check out https://www.5nplus.com.Currently Active Assets on Macroaxis
USOI | Credit Suisse X Links | |
ULTY | Tidal Trust II | |
CONY | YieldMax N Option | |
BCAT | BlackRock Capital Allocation | |
PDI | Pimco Dynamic Income |
Other Information on Investing in FPLSF Pink Sheet
5N Plus financial ratios help investors to determine whether FPLSF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FPLSF with respect to the benefits of owning 5N Plus security.